Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance

N Wellhausen, J Baek, SI Gill, CH June - Nature Reviews Cancer, 2024 - nature.com
Adoptive cell therapies engineered to express chimeric antigen receptors (CARs) or
transgenic T cell receptors (TCRs) to recognize and eliminate cancer cells have emerged as …

New strategies to treat AML: novel insights into AML survival pathways and combination therapies

R Nair, A Salinas-Illarena, HM Baldauf - Leukemia, 2021 - nature.com
The effective treatment of acute myeloid leukemia (AML) is very challenging. Due to the
immense heterogeneity of this disease, treating it using a “one size fits all” approach is …

An integrated genome-wide CRISPRa approach to functionalize lncRNAs in drug resistance

AC Bester, JD Lee, A Chavez, YR Lee, D Nachmani… - Cell, 2018 - cell.com
Resistance to chemotherapy plays a significant role in cancer mortality. To identify genetic
units affecting sensitivity to cytarabine, the mainstay of treatment for acute myeloid leukemia …

Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation

T Visnes, A Cázares-Körner, W Hao, O Wallner… - Science, 2018 - science.org
The onset of inflammation is associated with reactive oxygen species and oxidative damage
to macromolecules like 7, 8-dihydro-8-oxoguanine (8-oxoG) in DNA. Because 8-oxoguanine …

SAMHD1 promotes DNA end resection to facilitate DNA repair by homologous recombination

W Daddacha, AE Koyen, AJ Bastien, PSE Head… - Cell reports, 2017 - cell.com
DNA double-strand break (DSB) repair by homologous recombination (HR) is initiated by
CtIP/MRN-mediated DNA end resection to maintain genome integrity. SAMHD1 is a dNTP …

Nucleobase and nucleoside analogues: resistance and re-sensitisation at the level of pharmacokinetics, pharmacodynamics and metabolism

N Tsesmetzis, CBJ Paulin, SG Rudd, N Herold - Cancers, 2018 - mdpi.com
Antimetabolites, in particular nucleobase and nucleoside analogues, are cytotoxic drugs
that, starting from the small field of paediatric oncology, in combination with other …

Deficiency for SAMHD1 activates MDA5 in a cGAS/STING-dependent manner

T Schumann, SC Ramon, N Schubert… - Journal of Experimental …, 2022 - rupress.org
Defects in nucleic acid metabolizing enzymes can lead to spontaneous but selective
activation of either cGAS/STING or RIG-like receptor (RLR) signaling, causing type I …

SAMHD1 functions and human diseases

SAA Coggins, B Mahboubi, RF Schinazi, B Kim - Viruses, 2020 - mdpi.com
Deoxynucleoside triphosphate (dNTP) molecules are essential for the replication and
maintenance of genomic information in both cells and a variety of viral pathogens. While the …

Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia

VY Ling, J Straube, W Godfrey, R Haldar… - Leukemia, 2023 - nature.com
Chemotherapy-resistant acute myeloid leukemia (AML), frequently driven by clonal
evolution, has a dismal prognosis. A genome-wide CRISPR knockout screen investigating …

De-ubiquitination of SAMHD1 by USP7 promotes DNA damage repair to overcome oncogenic stress and affect chemotherapy sensitivity

J Liu, T Zhou, X Dong, Q Guo, L Zheng, X Wang… - Oncogene, 2023 - nature.com
Oncogenic stress induces DNA damage repair (DDR) that permits escape from mitotic
catastrophe and allows early precursor lesions during the evolution of cancer. SAMHD1, a …